Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Vertex Trial on Hold

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on May 02, 2022 1:36pm

146 Views

Post# 34648202

RE:RE:RE:RE:RE:RE:Vertex Trial on Hold

MS hopefully a major licensing deal will be the validation needed to at least start the recognization as the leader in the space. After today it is pretty obviouse who is leading but with validation and showing insulin indepence with out a top up I dont think it can be ignored. The spec at that point gets pretty real when you combine confromal coating, iPSC cells and high capacity pouch in Phase 3 and really go for the home run.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market